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Abstract
Introduction: Non-Hodgkin lymphoma (NHL) can involve the paratesticular organs as the primary disease, as
primary testicular lymphoma that secondarily involves the paratesticular structures, as the initial site of presentation
of occult nodal disease or as the result of disease dissemination. Primary follicular lymphoma of the epididymis in
an adult is extremely rare. Little is known about primary adult paratesticular/epididimal lymphomas.
Case presentation: We report a rare case of primary follicular non-Hodgkin lymphoma of the epididymis in a 90-
year-old Caucasian man who presented with a left scrotal mass. Bone marrow biopsy was negative and computed
tomography of the total body revealed no evidence of extratesticular involvement. Macroscopically, the epididymis
was replaced completely by a uniform mass. Histologic studies revealed a dense lymphoid infiltrate predominantly
composed of centrocytes with admixed centroblasts. Immunohistochemical analyses demonstrated that neoplastic
cells strongly expressed CD45RB, CD20, CD79a, bcl-6 and CD10; bcl-2 immunostaining was negative. Molecular
studies showed the presence of the monoclonal IgH gene rearrangement and the IgH/BCL2 rearrangement. The
lymphoma was classified as follicular lymphoma, low grade, grade 1-2. The patient subsequently underwent radical
orchiectomy, did not receive chemotherapy and post-operative follow-up showed absence of disease recurrence.
Conclusions: The case of primary follicular lymphoma of epididymis, reported here, is considered a very rare event.
It is characterized by clinically indolent localized disease, a good clinical outcome, lack of expression of BCL2
protein and the presence of the t(14;18)(q32;q21)/IGH-BCL2. Even if it is a single case, the primary follicular
lymphoma epididymis with t(14;18) could represent either a variant of the previously reported t(14;18)-negative
primary paratesticular follicular lymphoma or a distinct biological entity. To report additional cases in the future
would be helpful in resolving this question.
Introduction
Non-Hodgkin lymphoma (NHL) can involve the parates-
ticular organs as the primary disease, as primary testicu-
lar lymphoma that secondarily involves the
paratesticular structures, as the initial site of presenta-
tion of occult nodal disease or as the result of disease
dissemination. Primary lymphoma of the paratesticular
organs, without testicular or systemic involvement, is an
unusual observation [1]. Primary NHL of the epididymis
is a rare pathological event and is extremely rare in an
adult [2,3]. When present, epididymal involvement is
generally associated with testicular primary lymphoma
or is a finding of systemic disease [4].
Nodal follicular lymphoma is one of the most com-
mon types of NHL and accounts for approximately 20%
to 30% of cases in adults, but testicular and paratesticu-
lar primary follicular NHL is an unusual event.
Primary epididymal lymphomas often occur in older
men, have an intermediate or high grade and follow an
aggressive clinical course.
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ticular lymphoma described by Abel et al.[ 5 ]a n di n
five of 11 cases reported by Johnson et al.[ 6 ] ;i nt h e
series reported by Ferry et al. involvement of epididymis
was found in 63% of testicular lymphomas. Predominant
epididymal involvement may simulate primary epididy-
mal lymphoma: epididymis was more extensively
involved than the testis in three of 43 cases reported by
Ferry et al. [7].
Primary epididymal lymphoma without testicular or
systemic involvement was reported by Novella et al. [8],
Suzuki et al. [9] and Inoue et al. [10]. In 1979 Schned et
al., reported a case of primary histiocytic lymphoma of
the epididymis [11]. Heaton and Morales reported a sec-
ond case in 1983 [12] and Ginaldi et al. in 1993
described a 68-year-old man with a primary epididymal
lymphoma [4]. In 1995 McDermott et al.r e p o r t e da
case in a 34-year-old man [13]. Also, in 1995 Kausch et
al. reported the first case of primary mucosa-associated
lymphoid tissue (MALT) of the epididymis [14]. Okabea
et al. reported a case of primary lymphoma of the sper-
matic cord with involvement of epidydimis but not testis
[15].
To the best of our knowledge, little information about
adult primary follicular NHL of the testis and epididy-
mis is available. We report here a rare case of primary
follicular NHL of the epididymis in a 90-year-old man
with immunophenotypical and genetic characterization.
Case presentation
A 90-year-old Caucasian man, in otherwise good health,
presented with a left scrotal mass that had been present
for eight months and was occasionally painful. The man
had no fever, weight loss or night sweats; there was no
lymphadenopathy, hepatosplenomegaly or mass in the
right testis.
The patient underwent left radical orchiectomy.
Macroscopically, the specimen consisted of testis, epidi-
dymis and spermatic cord. On the cut surface, the epidi-
dymis was replaced completely by a uniform tan mass
that measured 6 × 3 cm without areas of necrosis or
hemorrhage. No invasive lesions were observed in the
testis and spermatic cord and the neoplastic tissue was
restricted to the epididymis.
Microscopically, the testicular parenchyma showed no
evidence of lymphomatous involvement (Figure 1a). The
epididymis contained a dense lymphoid infiltrate predo-
minantly composed of small cleaved cells (centrocytes)
with admixed small and large non-cleaved cells (centro-
blasts). The number of centroblasts ranged between five
and 15. The neoplasm predominantly displayed a folli-
cular growth pattern (Figures 1b and 1c). Neoplastic fol-
licles were quite expansive and irregular and were
coalescent in some areas. Well formed mantle zones
were absent. No tangible-body macrophages were
present.
Immunohistochemistry (IHC) investigation demon-
strated that neoplastic cells strongly expressed CD45RB
(LCA, clone 2B11+PD7/26, Dako), CD20 (clone L26,
Dako), CD79a (clone JCB117, Dako), bcl-6 (clone PG-
B6p, Dako) and CD10 (clone 56C6, Dako) (Figures 1d
and 1e). On the other hand, staining for CD3 (clone
F7.2.38, Dako), CD45RO (clone UCHL1, Dako), CD5
(clone 4C7, Thermo Scientific), CD23 (clone SP23,
Dako) and bcl-2 (clone 124, Dako and clone 100/D5,
Novocastra) were negative (Figure 1F). Immunostaining
for CD21/CD35 (clone 1F8/Ber-MAC-DRC, Dako)
demonstrated expanded networks of follicular dendritic
cells within the nodules. Approximately 60% of the neo-
plastic cells reacted positively when stained with anti-
body against Ki-67 (clone MIB1, Dako). The
proliferation index of follicular lymphoma generally cor-
relates with tumor grade. The proliferation index
reported here was independently performed by more
than one pathologist and, although it is somewhat high
for a low grade follicular lymphoma, discordances are
known to occur in follicular lymphoma [16]. Finally,
polymerase chain reaction (PCR) analysis revealed a
monoclonal immunoglobulin heavy chain gene rearran-
gement and the detection of t(14;18)(IgH/BCL2)
revealed the BCL/JH rearrangement (Figures 2a and 2b).
The lymphoma was classified on the basis of the World
Health Organization’s (WHO) 2008 guidelines as follicu-
lar lymphoma, low grade, grade 1-2, with follicular pat-
tern. The disease was staged as IE (extranodal) primary
epididymal lymphoma. Commercial kits by AB Analitica
(Padua, Italy) were used to perform both procedures
according to the manufacturer’si n s t r u c t i o n s .A l lu s e d
products are compliant with the requirements of the in
vitro diagnostic directive (IVDD) 98/79/EC. IHC and
molecular analyses were carried out as previously
described [17-20].
The patient underwent full staging for lymphoma,
including computed tomography of the total body which
did not reveal any evidence of extratesticular involve-
ment (image not shown) and did not receive chemother-
apy. Bone marrow biopsy showed no evidence of
lymphoma (data not shown). A post-operative follow-up
of more than 15 months has been uneventful, without
disease recurrence.
Discussion
This report describes an unusual case of primary folli-
cular non- Hodgkin lymphoma (NHL) of the epididy-
mis in a 90-year-old man. The diagnosis was
supported both by histology and phenotypic or genoty-
pic expression of clonality. Although, the majority of
follicular lymphomas arise in the lymph nodes, a
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including the gastrointestinal tract, skin, ocular adnexa,
breast and testis [21]. Several studies report that pri-
mary testicular lymphomas are almost always repre-
sented by diffuse large B-cell lymphoma and mainly
affect older adults with frequent dissemination and
poor prognosis [21-24]. A small number of testicular
lymphomas are follicular lymphomas, mainly affecting
children [25-29], but adults also develop testicular fol-
licular lymphoma in rare cases [30-34].
After reviewing the literature, we found only a few
cases of primary adult paratesticular and/or epididimal
lymphomas. These lymphomas have been well
characterized.
Figure 1 Histological and immunohistochemical findings.( a) The testicular parenchyma shows no evidence of lymphomatous involvement
(hematoxylin-eosin, original magnification ×50). (b-c) Residual epididymal tubules are surrounded by a dense cellular infiltrate with a prevalent
follicular architecture (hematoxylin-eosin, original magnification ×100 and ×630, respectively). The neoplastic cells strongly express CD20 (d) and
CD10 (e) but are bcl-2 negative (f) (original magnification ×250).
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primary site is very unusual for testicular follicular lym-
phoma and patients with these lymphomas have an
excellent clinical outcome [21].
With respect to immunophenotypic and cytogenetic
features, some extranodal follicular lymphomas such as
those involving the gastrointestinal tract, are similar to
those of nodal origin, in which bcl-2 protein is usually
expressed and the translocation involving bcl-2 and IgH
genes is frequently detected [21].
Other lymphomas, such as those involving the skin
and testis, are typically negative for bcl-2 protein and
have no bcl-2 gene rearrangement when this has been
evaluated [21].
Bacon et al. described five cases of primary follicular
lymphoma of the testis and epididymis in adults charac-
terized by immunophenotypic expression of CD10 and
BCL6, which lacked immunophenotypic expression of
BCL2 and lacked t(14;18)(q32;q21)/IGH-BCL2 and
BCL6 rearrangements [31]. The same features have been
found in lymphomas in children [26-28].
Other studies report that the majority of bcl-2-nega-
tive nodal follicular lymphomas lacks a t(14;18) but a
significant subset of these tumors are false negative; the
presence of somatic mutations in the translocated BCL2
gene results in amino acid replacements in the region of
the epitope recognized by the antibody [35].
Our case is characterized on histology by the presence
of small cleaved cells, displaying predominantly a
follicular growth pattern. In addition, we used bcl-2
immunostaining, with alternative monoclonal antibodies
(124 and 100/D5 clones), to help in the diagnosis of fol-
licular lymphoma and to reduce false negatives, since
reactive follicular center cells are negative for bcl-2.
However, extranodal follicular NHL are often non reac-
tive to bcl-2.
In the epididymis, phenotypically we found cells posi-
tive for bcl-6 and CD10 and negative for bcl-2.
To confirm the presence of the lymphoma, Ig gene
rearrangement analysis using PCR was performed. The
analysis showed the presence of the monoclonal IgH
gene rearrangement.
Finally, we investigated the t(14;18)(IgH/BCL2) rear-
rangement, since the bcl-2 gene translocation is present
in the majority of nodal follicular lymphomas and is
involved in the t(14;18) reciprocal translocation with the
IgH locus. Since this translocation was present, we con-
firmed the diagnosis of follicular lymphoma, low grade,
grade 1-2 (WHO 2008).
Lack of expression of the bcl-2 protein simultaneous
with the presence of the t(14;18) can be explained by
the fact that the traslocation could cause somatic hyper-
mutation of the bcl-2 gene sequence encoding the epi-
tope recognized by the antibody, whereby the neoplastic
cells appear negative for bcl-2 protein despite having t
(14;18).
In conclusion, on the basis of data from our case and
from the literature, whatever the roles of protein bcl-2
expression and/or bcl-2 gene rearrangement, there is no
significant correspondence with clinical behavior [36].
Conclusions
The case of primary follicular lymphoma of epididymis,
reported here, is considered a very rare event.
It is characterized by clinically indolent localized dis-
ease, a good clinical outcome, lack of expression of
BCL2 protein and the presence of t(14;18)(q32;q21)/
IGH-BCL2.
Even if it is a single case, the primary follicular lym-
phoma epididymis with t(14;18) could represent either a
variant of the previously reported t(14;18)-negative pri-
mary paratesticular follicular lymphoma or a distinct
biological entity (perhaps more closely related to indo-
lent BCL2 rearranged follicular lymphoma in other
sites). To report additional cases in the future would be
helpful in resolving this question.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Figure 2 Molecular findings.( a) Agarose gel electrophoresis to
detect the rearrangement of the immunoglobulin heavy chain (IgH)
rearrangement PCR products (semi-nested PCR). Lane 1: patient
sample; lane 2: negative control (no DNA); lane 3: polyclonal control;
lane 4: monoclonal control; lane MK: DNA ladder (501, 404, 331, 242,
190,147,111, 67, 34 bp fragments). (b) Agarose gel electrophoresis to
detect BCL2/JH PCR products (nested PCR). Lane 1: negative control
(no DNA); lane 2: patient sample; lane 3: BCL2 MBR positive control
(plasmidic DNA containing BCL2/MBR rearrangement); lane MK: DNA
ladder (501, 404, 331, 242, 190,147,111, 67, 34 bp fragments).
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